Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Template:SubstanceBox/Gabapentin: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
>Kenan
m Reverted edits by Isaak (talk) to last revision by Natzki
>Isaak
Common names correctly annotated.
Line 41: Line 41:


     <!-- Nomenclature -->
     <!-- Nomenclature -->
     |NameCommon=Gabapentin, Neurontin, Gabarone, Gralise
     |NameCommon=[[common name::Gabapentin]], [[common name::Neurontin]], [[common name::Gabarone]], [[common name::Gralise]]
     |NameSubstitution=Gabapentin
     |NameSubstitution=Gabapentin
     |NameSystematic=1-(Aminomethyl)cyclohexaneacetic acid
     |NameSystematic=1-(Aminomethyl)cyclohexaneacetic acid

Revision as of 23:56, 12 May 2022

SubstanceBox/Gabapentin
Chemical Nomenclature
Common names Gabapentin, Neurontin, Gabarone, Gralise
Substitutive name Gabapentin
Systematic name 1-(Aminomethyl)cyclohexaneacetic acid
Class Membership
Psychoactive class Depressant
Chemical class Gabapentinoid
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.



Oral
Dosage
Bioavailability 27% - 60%[1]
Threshold 200 mg
Light 200 - 900 mg
Common 900 - 1500 mg
Strong 1500 - 2400 mg
Heavy 2400 mg +
Duration
Total 6 - 10 hours
Onset 30 - 120 minutes
Peak 120 - 180 minutes









DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

  1. "Gabapentin dosing, indications, interactions, adverse effects, and more". | http://reference.medscape.com/drug/neurontin-gralise-gabapentin-343011#showall